Pay in 4 interest-free payments of $5.00 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Neither is FDA-approved for human use
Although GLP-1RAs can reduce body weight by 15%25% in controlled settings, real-world adherence is limited, and nearly 70% of patients experience weight regain after discontinuation, raising the risk of long-term pharmacological dependence ( Looking ahead, the future of GLP-1based therapy will depend on addressing safety concerns, improving long-term adherence, and expanding clinical indications
&srotate=0)
Plateau experiences are rare during this phase but possible
At the same time: Muscle mass gradually declines Energy expenditure decreases Insulin sensitivity may worsen The result is a pattern many women recognise but struggle to explain
Common side effects may include: Nausea Diarrhea Decreased appetite Vomiting Constipation Indigestion Contact your doctor if side effects are severe or do not go away
